New Study Conducted at Sheppard Pratt Finds Psilocybin-Assisted Therapy May Reduce Chronic Suicidal IdeationMorningStar·May 26 at 12:50 PMMNMD0.00%CMPS+2.54%
FDA Moves To Fast-Track Psychedelic Therapies For Mental Healthrttnews·Apr 24 at 04:50 PMATAI+0.20%CYBN0.00%
Trump Order To Accelerate Treatments For Serious Mental Illnessrttnews·Apr 20 at 06:37 AMCMPS+2.54%MNMD0.00%
Trump: Accelerate access to research on psychedelic drugsWallstreetcn·Apr 18 at 08:14 AMGHRS+3.24%MNMD0.00%
Women's health startup Midi Health hit a $1 billion valuation. Its founder says AI changed everything.businessinsider·Apr 14 at 11:02 PMMNMD0.00%FBT+0.75%
11:03 ETSonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systemsprnewswire·Mar 24 at 10:05 AMSOND0.00%BBH+0.06%
NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver DiseaseThe newswire.ca·Mar 11 at 06:30 AMPBE+0.81%XBI+2.46%
Clearmind Medicine partners to develop intranasal MEAI for addiction & CNS disorders, boosting bioavailability & clinical progress.Unusual Whales·Feb 6 at 06:56 AMIXJ+0.28%XBI+2.46%
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Short Interest UpdateMarket Beat·Jan 19 at 10:19 PMMNMD0.00%
Mind Medicine MindMed | 10-Q: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 6, 2025 at 04:06 PMMNMD0.00%DFTX+3.19%
Mind Medicine MindMed | 8-K: FY2025 Q3 Revenue: USD 0Earnings Watch·Nov 6, 2025 at 03:50 PMMNMD0.00%DFTX+3.19%
